Cargando…

A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome

OBJECTIVE: SS is an autoimmune disease most commonly diagnosed in adults but can occur in children. Our objective was to assess the presence of chemokines, cytokines and biomarkers (CCBMs) in saliva from these children that were associated with lymphocyte and mononuclear cell functions. METHODS: Sal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez Hernandez, M Paula, Starman, Emily E, Davis, Andrew B, Withanage, Miyuraj Harishchandra Hikkaduwa, Zeng, Erliang, Lieberman, Scott M, Brogden, Kim A, Lanzel, Emily A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487313/
https://www.ncbi.nlm.nih.gov/pubmed/33512494
http://dx.doi.org/10.1093/rheumatology/keab098
_version_ 1784577929632546816
author Gomez Hernandez, M Paula
Starman, Emily E
Davis, Andrew B
Withanage, Miyuraj Harishchandra Hikkaduwa
Zeng, Erliang
Lieberman, Scott M
Brogden, Kim A
Lanzel, Emily A
author_facet Gomez Hernandez, M Paula
Starman, Emily E
Davis, Andrew B
Withanage, Miyuraj Harishchandra Hikkaduwa
Zeng, Erliang
Lieberman, Scott M
Brogden, Kim A
Lanzel, Emily A
author_sort Gomez Hernandez, M Paula
collection PubMed
description OBJECTIVE: SS is an autoimmune disease most commonly diagnosed in adults but can occur in children. Our objective was to assess the presence of chemokines, cytokines and biomarkers (CCBMs) in saliva from these children that were associated with lymphocyte and mononuclear cell functions. METHODS: Saliva was collected from 11 children diagnosed with SS prior to age 18 years and 16 normal healthy children. A total of 105 CCBMs were detected in multiplex microparticle-based immunoassays. ANOVA and t test (0.05 level) were used to detect differences. Ingenuity Pathway Analysis (IPA) was used to assess whether elevated CCBMs were in annotations associated with immune system diseases and select leukocyte activities and functions. Machine learning methods were used to evaluate the predictive power of these CCBMs for SS and were measured by receiver operating characteristic (ROC) curve and area under curve (AUC). RESULTS: Of the 105 CCBMs detected, 43 (40.9%) differed in children with SS from those in healthy study controls (P < 0.05) and could differentiate the two groups (P < 0.05). Elevated CCBMs in IPA annotations were associated with autoimmune diseases and with leukocyte chemotaxis, migration, proliferation, and regulation of T cell activation. The best AUC value in ROC analysis was 0.93, indicating that there are small numbers of CCBMs that may be useful for diagnosis of SS. CONCLUSION: While 35 of these 43 CCBMs have been previously reported in SS, 8 CCBMs had not. Additional studies focusing on these CCBMs may provide further insight into disease pathogenesis and may contribute to diagnosis of SS in children.
format Online
Article
Text
id pubmed-8487313
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84873132021-10-04 A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome Gomez Hernandez, M Paula Starman, Emily E Davis, Andrew B Withanage, Miyuraj Harishchandra Hikkaduwa Zeng, Erliang Lieberman, Scott M Brogden, Kim A Lanzel, Emily A Rheumatology (Oxford) Clinical Science OBJECTIVE: SS is an autoimmune disease most commonly diagnosed in adults but can occur in children. Our objective was to assess the presence of chemokines, cytokines and biomarkers (CCBMs) in saliva from these children that were associated with lymphocyte and mononuclear cell functions. METHODS: Saliva was collected from 11 children diagnosed with SS prior to age 18 years and 16 normal healthy children. A total of 105 CCBMs were detected in multiplex microparticle-based immunoassays. ANOVA and t test (0.05 level) were used to detect differences. Ingenuity Pathway Analysis (IPA) was used to assess whether elevated CCBMs were in annotations associated with immune system diseases and select leukocyte activities and functions. Machine learning methods were used to evaluate the predictive power of these CCBMs for SS and were measured by receiver operating characteristic (ROC) curve and area under curve (AUC). RESULTS: Of the 105 CCBMs detected, 43 (40.9%) differed in children with SS from those in healthy study controls (P < 0.05) and could differentiate the two groups (P < 0.05). Elevated CCBMs in IPA annotations were associated with autoimmune diseases and with leukocyte chemotaxis, migration, proliferation, and regulation of T cell activation. The best AUC value in ROC analysis was 0.93, indicating that there are small numbers of CCBMs that may be useful for diagnosis of SS. CONCLUSION: While 35 of these 43 CCBMs have been previously reported in SS, 8 CCBMs had not. Additional studies focusing on these CCBMs may provide further insight into disease pathogenesis and may contribute to diagnosis of SS in children. Oxford University Press 2021-01-29 /pmc/articles/PMC8487313/ /pubmed/33512494 http://dx.doi.org/10.1093/rheumatology/keab098 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Science
Gomez Hernandez, M Paula
Starman, Emily E
Davis, Andrew B
Withanage, Miyuraj Harishchandra Hikkaduwa
Zeng, Erliang
Lieberman, Scott M
Brogden, Kim A
Lanzel, Emily A
A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
title A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
title_full A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
title_fullStr A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
title_full_unstemmed A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
title_short A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
title_sort distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with sjögren’s syndrome
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487313/
https://www.ncbi.nlm.nih.gov/pubmed/33512494
http://dx.doi.org/10.1093/rheumatology/keab098
work_keys_str_mv AT gomezhernandezmpaula adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT starmanemilye adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT davisandrewb adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT withanagemiyurajharishchandrahikkaduwa adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT zengerliang adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT liebermanscottm adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT brogdenkima adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT lanzelemilya adistinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT gomezhernandezmpaula distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT starmanemilye distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT davisandrewb distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT withanagemiyurajharishchandrahikkaduwa distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT zengerliang distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT liebermanscottm distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT brogdenkima distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome
AT lanzelemilya distinguishingprofileofchemokinescytokinesandbiomarkersinthesalivaofchildrenwithsjogrenssyndrome